tranScrip
Stephanie Allampalli currently serves as Manager of Regulatory Affairs at tranScrip since April 2023. Previously, from October 2019 to April 2023, Stephanie worked as a Regulatory Affairs Consultant at Real Regulatory Ltd. and Real CMC, progressing from Regulatory Affairs Associate to Consultant. Prior experience includes a role as Regulatory Affairs Specialist at Alvogen Development Ltd., focusing on CMC regulatory affairs, and a position as Scientific Officer in Analytical Development at Actavis Ltd., where responsibilities included analysis and stability testing. Stephanie holds a Bachelor of Science in Biology and Chemistry (Hons) from the University of Malta, completed in 2010.
This person is not in any offices
tranScrip
tranScrip is a leading contract drug development organisation which supports pharma and biotech companies in the development and lifecycle of medicines. We bring innovative solutions to clients’ global drug development needs. From translational medicine through to registration and post licencing, we deliver both strategic leadership and operational execution of development programmes, covering clinical, regulatory, drug safety, and commercial elements. Our teams of physicians, scientists and regulatory experts, help clients select the most promising drug candidates and bring them to the market. We guide our clients through their decision making from first in man studies to proof of concept and pivotal trials, regulatory submissions and product launches. In the last decade, tranScrip has supported over 250 clients and has been integral to many development programmes and regulatory submissions, bringing products to the market each year across a wide range of therapeutic areas.